The DOI matches its Crossref record.
Time-resolved dual transcriptomics of Pseudomonas aeruginosa biofilm formation in cystic fibrosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Time-resolved dual omics approaches now monitor P. aeruginosa interactions with airway epithelial cells in real time.”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [258]
In the citing paper
“Dual RNA sequencing (RNA-seq) in organoids and air–liquid interface (ALI) cultures measures both host and bacterial transcripts during biofilm development and remodeling [256,257,258].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [258]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 45
- Flemming, 2016, Biofilms: an emergent form of bacterial life, Nat Rev Microbiol, 14, 563, 10.1038/nrmicro.2016.94 · DOI · Paper page
- Kuek, 2020, First contact: the role of respiratory cilia in host-pathogen interactions in the airways, Am J Physiol Lung Cell Mol Physiol, 319, L603, 10.1152/ajplung.00283.2020 · DOI · Paper page
- Hewitt, 2021, Regulation of immune responses by the airway epithelial cell landscape, Nat Rev Immunol, 21, 347, 10.1038/s41577-020-00477-9 · DOI · Paper page
- Hauser, 2009, The type III secretion system of pseudomonas aeruginosa: infection by injection, Nat Rev Microbiol, 7, 654, 10.1038/nrmicro2199 · DOI · Paper page
- Crua Asensio, 2017, Centrality in the host-pathogen interactome is associated with pathogen fitness during infection, Nat Commun, 8, 10.1038/ncomms14092 · DOI
- Mesas Vaz, 2024, The battle within: how Pseudomonas aeruginosa uses host-pathogen interactions to infect the human lung, Crit Rev Microbiol, 1–36
- Hauser, 2011, Clinical significance of microbial infection and adaptation in cystic fibrosis, Clin Microbiol Rev, 24, 29, 10.1128/CMR.00036-10 · DOI · Paper page
- Crull, 2018, Changing rates of chronic Pseudomonas aeruginosa infections in cystic fibrosis: a population-based cohort study, Clin Infect Dis, 67, 1089, 10.1093/cid/ciy215 · doi:10.1093/cid/ciy215
- Sherrard, 2014, Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis, Lancet, 384, 703, 10.1016/S0140-6736(14)61137-5 · DOI
- Rossi, 2021, Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis, Nat Rev Microbiol, 19, 331, 10.1038/s41579-020-00477-5 · DOI · Paper page
- La Rosa, 2021, Compensatory evolution of pseudomonas aeruginosa's slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis, Nat Commun, 12, 3186, 10.1038/s41467-021-23451-y · DOI
- Palmer, 2005, Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology, J Bacteriol, 187, 5267, 10.1128/JB.187.15.5267-5277.2005 · DOI · Paper page
- Maurice, 2018, Pseudomonas aeruginosa biofilms: host response and clinical implications in lung infections, Am J Respir Cell Mol Biol, 58, 428, 10.1165/rcmb.2017-0321TR · DOI · Paper page
- Crabbe, 2014, Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa, Pathog Dis, 71, 1, 10.1111/2049-632X.12180 · DOI
- Baldassi, 2021, Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions, Adv Nanobiomed Res, 1, 10.1002/anbr.202000111 · DOI · Paper page
- Swart, 2024, Pseudomonas aeruginosa breaches respiratory epithelia through goblet cell invasion in a microtissue model, Nat Microbiol, 9, 1725, 10.1038/s41564-024-01718-6 · DOI
- Laborda, 2024, Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance, Nat Commun, 15, 2584, 10.1038/s41467-024-46938-w · DOI
- Meirelles, 2024, Pseudomonas aeruginosa faces a fitness trade-off between mucosal colonization and antibiotic tolerance during airway infection, Nat Microbiol, 9, 3284, 10.1038/s41564-024-01842-3 · DOI · Paper page
- Zabner, 2003, Development of cystic fibrosis and noncystic fibrosis airway cell lines, Am J Physiol Lung Cell Mol Physiol, 284, L844, 10.1152/ajplung.00355.2002 · DOI · Paper page
- Kovach, 2017, IL-36gamma is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia, Mucosal Immunol, 10, 1320, 10.1038/mi.2016.130 · DOI
- Gurczynski, 2018, IL-17 in the lung: the good, the bad, and the ugly, Am J Physiol Lung Cell Mol Physiol, 314, L6, 10.1152/ajplung.00344.2017 · DOI · Paper page
- Wolf, 2016, IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia, Am J Physiol Lung Cell Mol Physiol, 311, L1015, 10.1152/ajplung.00158.2016 · DOI
- Jeon, 2020, IL-17C protects nasal epithelium from Pseudomonas aeruginosa infection, Am J Respir Cell Mol Biol, 62, 95, 10.1165/rcmb.2018-0377OC · DOI
- Rutz, 2014, The IL-20 subfamily of cytokines--from host defence to tissue homeostasis, Nat Rev Immunol, 14, 783, 10.1038/nri3766 · DOI · Paper page
- Starner, 2003, CCL20 is an inducible product of human airway epithelia with innate immune properties, Am J Respir Cell Mol Biol, 29, 627, 10.1165/rcmb.2002-0272OC · DOI
- Tang, 2022, Evaluating bacterial pathogenesis using a model of human airway organoids infected with Pseudomonas aeruginosa biofilms, Microbiol Spectr, 10, 10.1128/spectrum.02408-22 · DOI
- Workman, 2015, The role of bitter and sweet taste receptors in upper airway immunity, Curr Allergy Asthma Rep, 15, 72, 10.1007/s11882-015-0571-8 · DOI
- Carey, 2023, Loss of CFTR function is associated with reduced bitter taste receptor-stimulated nitric oxide innate immune responses in nasal epithelial cells and macrophages, Front Immunol, 14, 10.3389/fimmu.2023.1096242 · DOI
- Cohen-Cymberknoh, 2013, Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications, Thorax, 68, 1157, 10.1136/thoraxjnl-2013-203204 · DOI · Paper page
- Bao, 2018, Serpin functions in host-pathogen interactions, PeerJ, 6, 10.7717/peerj.4557 · DOI
- Higashi, 2019, Expression profiling of fibroblasts in chronic and acute disease models reveals novel pathways in kidney fibrosis, J Am Soc Nephrol, 30, 80, 10.1681/ASN.2018060644 · DOI
- Qiu, 2021, A novel prognostic signature for idiopathic pulmonary fibrosis based on five-immune-related genes, Ann Transl Med, 9, 1570, 10.21037/atm-21-4545 · DOI
- Steinert, 1998, Small proline-rich proteins are cross-bridging proteins in the cornified cell envelopes of stratified squamous epithelia, J Struct Biol, 122, 76, 10.1006/jsbi.1998.3957 · DOI
- Herrera, 2021, The IPF fibroblastic focus is an active collagen biosynthesis factory embedded in a distinct extracellular matrix, bioRxiv, 2021.2011.2006
- Chua, 2020, COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis, Nat Biotechnol, 38, 970, 10.1038/s41587-020-0602-4 · DOI · Paper page
- Jiao, 2019, Epithelial physical barrier defects in chronic rhinosinusitis, Expet Rev Clin Immunol, 15, 679, 10.1080/1744666X.2019.1601556 · DOI
- Lewin, 2023, Application of a quantitative framework to improve the accuracy of a bacterial infection model, Proc Natl Acad Sci U S A, 120, 10.1073/pnas.2221542120 · DOI
- Llamas, 2008, Characterization of five novel Pseudomonas aeruginosa cell-surface signalling systems, Mol Microbiol, 67, 458, 10.1111/j.1365-2958.2007.06061.x · DOI
- Cornforth, 2018, Pseudomonas aeruginosa transcriptome during human infection, Proc Natl Acad Sci U S A, 115, E5125, 10.1073/pnas.1717525115 · DOI · Paper page
- de Groot, 2020, Bacteria use structural imperfect mimicry to hijack the host interactome, PLoS Comput Biol, 16, 10.1371/journal.pcbi.1008395 · DOI
- Gomez Borrego, 2022, Analysis of host-bacteria protein interactions reveals conserved domains and motifs that mediate fundamental infection pathways, Int J Mol Sci, 23, 10.3390/ijms231911489 · DOI
- Rendón, 2020, BacFITBase: a database to assess the relevance of bacterial genes during host infection, Nucleic Acids Res, 48, D511
- Crua Asensio, 2021, Time-resolved transcriptional profiling of epithelial cells infected by intracellular Acinetobacter baumannii, Microorganisms, 9, 10.3390/microorganisms9020354 · DOI
- de Groot, 2019, Coordinated response at the transcriptome and interactome level is required to ensure uropathogenic Escherichia coli survival during bacteremia, Microorganisms, 7, 10.3390/microorganisms7090292 · doi:10.3390/microorganisms7090292
- Macho Rendon, 2021, The host-pathogen dual RNA sequencing database for infection processes, Nucleic Acids Res, 49, D687, 10.1093/nar/gkaa890 · doi:10.1093/nar/gkaa890
Cited by
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Metadata
- Authors
- Asensio, N. C., Rendón, J. M., González López, J. J., Tizzano, S. G., Martín Gómez, M. T., & Burgas, M. T.
- ORCID
- Burgas, Marc Torrent
- Venue
- Biofilm
- Publisher
- Elsevier BV
- Published
- 2025-12
- Volume
- 10
- Pages
- 100301
- ISSN
- 2590-2075
- Cited by
- 3
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- Funders
- Federación Española de Enfermedades Raras
- Universitat Autònoma de Barcelona
- Ministerio de Ciencia e Innovación (SAF2017-82158-R, PDC2021-121544-I00, PID2020-114627RB-I00, PID2023-152706OB-I00, MICIU/AEI/10.13039/501100011033)
- European Society of Clinical Microbiology and Infectious Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Time-resolved dual transcriptomics of Pseudomonas aeruginosa biofilm formation in cystic fibrosis. https://app.cochat.ai/papers/10.1016/j.bioflm.2025.100301
- The paper
- Asensio, N. C., Rendón, J. M., González López, J. J., Tizzano, S. G., Martín Gómez, M. T., & Burgas, M. T. (2025). Time-resolved dual transcriptomics of Pseudomonas aeruginosa biofilm formation in cystic fibrosis. Biofilm. https://doi.org/10.1016/j.bioflm.2025.100301
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.